Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humacyte Inc (HUMA)

Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Humacyte Inc 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 USA

www.humacyte.com Employees: 220 P: 919-313-9633

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 107,587
Enterprise Value, $K 92,527
Shares Outstanding, K 187,271
Float, K 177,720
% Float 94.90%
Short Interest, K 40,676
Short Float 21.72%
Days to Cover 10.36
Short Volume Ratio 0.61
% of Insider Shareholders 5.10%
% of Institutional Shareholders 44.71%

Financials:

Annual Sales, $ 2,040 K
Annual Net Income, $ -40,830 K
Last Quarter Sales, $ 470 K
Last Quarter Net Income, $ -24,800 K
EBIT, $ -108,140 K
EBITDA, $ -100,790 K

Growth:

1-Year Return -69.64%
3-Year Return -82.16%
5-Year Return -94.87%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/12/25
Next Earnings Date 05/12/26
Earnings Per Share ttm -0.61
EPS Growth vs. Prev Qtr 7.14%
EPS Growth vs. Prev Year 18.75%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

HUMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -808.20%
Return-on-Assets % -72.71%
Profit Margin % -2,001.47%
Debt/Equity 11.40
Price/Sales 62.08
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.02
Interest Coverage -2.63
60-Month Beta 1.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.